Carotid intima media thickness is related positively to plasma pre ß-high density lipoproteins in non-diabetic subjects.
暂无分享,去创建一个
A. van Tol | R. Dullaart | Robin P F Dullaart | Rindert de Vries | Frank G Perton | Arie van Tol | R. de Vries | F. Perton
[1] T. Egashira,et al. Association of coronary heart disease with pre-beta-HDL concentrations in Japanese men. , 2004, Clinical chemistry.
[2] C. Fielding,et al. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.
[3] T. Forte,et al. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. , 1992, Biochimica et biophysica acta.
[4] S. Eisenberg,et al. High density lipoprotein metabolism. , 1984, Journal of lipid research.
[5] A. Tall,et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.
[6] A. van Tol,et al. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[7] A. Hofman,et al. Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility , 2010, Circulation.
[8] A. Tol. Phospholipid transfer protein. , 2002 .
[9] I. Godsland. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. , 2001, Fertility and sterility.
[10] M. Taskinen,et al. Decreased High-Density Lipoprotein (HDL) Particle Size, Pre&bgr;-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[11] J. Danesh,et al. Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.
[12] T. Miida,et al. Pre beta 1-high-density lipoprotein increases in coronary artery disease. , 1996, Clinical chemistry.
[13] B. Wolffenbuttel,et al. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. , 2008, Atherosclerosis.
[14] S. Peters,et al. Attenuation of Rate of Change in Carotid Intima-Media Thickness by Lipid-Modifying Drugs , 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[15] E. Schaefer,et al. Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[16] Inder Singh,et al. High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.
[17] B. Wolffenbuttel,et al. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion. , 2011, Cardiovascular therapeutics.
[18] P. Barter,et al. Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[19] R. Dullaart,et al. Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins , 2003, European journal of clinical investigation.
[20] P. Duchateau,et al. Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender. , 1998, Journal of lipid research.
[21] L. Cupples,et al. High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[22] G. Franceschini,et al. Depletion of Pre-β-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein* , 2004, Journal of Biological Chemistry.
[23] B. Dahlbäck,et al. Apolipoprotein M predicts pre‐β‐HDL formation: studies in type 2 diabetic and nondiabetic subjects , 2009, Journal of internal medicine.
[24] Serkalem Demissie,et al. Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[25] A. Smit,et al. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus , 2006, Diabetologia.
[26] M. Seishima,et al. Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease. , 2005, Clinical chemistry.
[27] R. Collins,et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.
[28] Børge G Nordestgaard,et al. High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol. , 2010, Clinical chemistry.
[29] C. Fielding,et al. Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. , 1987, Journal of lipid research.
[30] A. Groen,et al. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment , 2005, Diabetologia.
[31] F. Grosveld,et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[32] R H Selzer,et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. , 1994, Atherosclerosis.
[33] Gerard E. Dallal,et al. Change in &agr;1 HDL Concentration Predicts Progression in Coronary Artery Stenosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[34] P. Barter,et al. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. , 1998, Journal of lipid research.
[35] G. Dallinga-Thie,et al. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein. , 2009, Biochimica et biophysica acta.
[36] J. Pais de Barros,et al. Worsening of Diet-Induced Atherosclerosis in a New Model of Transgenic Rabbit Expressing the Human Plasma Phospholipid Transfer Protein , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[37] T. van Gent,et al. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200166-JLR200 , 2002, Journal of Lipid Research.
[38] R. Krauss,et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. , 2011, Clinical chemistry.
[39] A. Tall,et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency , 2001, Nature Medicine.
[40] P. Barter,et al. Remodelling of high density lipoproteins by plasma factors. , 1999, Atherosclerosis.
[41] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[42] E. Schaefer,et al. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. , 2007, The American journal of cardiology.
[43] Christian Zellner,et al. Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease. , 2011, The American journal of cardiology.